Clients who currently receive dealer counterparty data for OTC derivatives via ValueLink products will now also be able to access independent valuations for these instruments generated by OTC Val. This is a significant extension of the current OTC data service provided by ValueLink, which has previously concentrated on counterparty pricing.
Bob Sangha, Managing Director at OTC Val said “We are very excited to be working with ValueLink in providing an independent valuations solution for OTC derivatives. OTC derivative activity has exploded in recent years but the development of independent valuations of derivative positions has been slower to develop. OTC Valuations is a leading provider of independent valuations of derivatives and other complex financial products and provides a complement to, and ... more »

